Metraipolis › archive › dc_392edbbf44b2

Development of a Novel Shigella Quadrivalent Conjugate Vaccine Using Shigella O-Polysaccharide and IpaB Carrier Protein — Europe PMC PMID:41746057

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41746057
DOI
10.3390/vaccines14020134
License (as archived)
solo-consultazione
Archived
2026-11-06T11:45:16.349Z
SHA-256 of the archived text
8509fff26867442f0d126af5a4d70f5fb6c1a11e5c2e3f94d791a216e974e624
Stable URL of this page
https://metraipolis.com/documento/dc_392edbbf44b2

How to cite

Development of a Novel Shigella Quadrivalent Conjugate Vaccine Using Shigella O-Polysaccharide and IpaB Carrier Protein — Europe PMC PMID:41746057 — Europe PMC (en), https://europepmc.org/article/MED/41746057 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_392edbbf44b2 (Metraipolis archive dc_392edbbf44b2, sha256 8509fff26867442f0d126af5a4d70f5fb6c1a11e5c2e3f94d791a216e974e624)
BibTeX
@misc{dc392edbbf44b2,
  title = {Development of a Novel Shigella Quadrivalent Conjugate Vaccine Using Shigella O-Polysaccharide and IpaB Carrier Protein — Europe PMC PMID:41746057},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41746057},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_392edbbf44b2; sha256 8509fff26867442f0d126af5a4d70f5fb6c1a11e5c2e3f94d791a216e974e624},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41746057. Agents can read the archived copy with the MCP tool read_document.